Please Wait
Applying Filters...
menu
    • menu
    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Munit offers scalable GMP micronization and particle size engineering to enhance drug solubility, bioavailability, and performance.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-03

    Virtual Booth

    An Enquiry

    Mission CDMO team brings reliability, resourcefulness, & responsiveness in executing your development project.

    Virtual Booth

    Contact Supplier

    Jai Radhe Sales is your partner for all your sourcing needs.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Tryptamine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    PharmaCompass
    $ API Ref.Price (USD/KG) : 147Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Enveric Biosciences Publishes Articles on Innovative
    Enveric Biosciences Publishes Articles on Innovative

    17 Sep 2025

    // PHARMAWEB

    https://www.pharmiweb.com/press-release/2025-09-17/enveric-biosciences-announces-publication-of-two-peer-reviewed-articles-highlighting-novel-bioproduc

    PHARMAWEB
    17 Sep 2025
    Share Share
    Enveric Gets Notice for Low-Hallucinogenic Neuroplastogens
    Enveric Gets Notice for Low-Hallucinogenic Neuroplastogens

    10 Jun 2025

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20250610204639/en/Enveric-Biosciences-Receives-Notice-of-Allowance-for-New-Class-of-Low-Hallucinogenic-Neuroplastogens-Targeting-Psychiatric-Disorders

    BUSINESSWIRE
    10 Jun 2025
    Share Share
    ASRI: Global Patent Filings For Novel Empathogens, Tryptamines
    ASRI: Global Patent Filings For Novel Empathogens, Tryptamines

    28 May 2024

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/asri-expands-global-reach-with-patent-filings-for-innovative-empathogens-tryptamines-and-phenylalkylamines-302156325.html

    PR NEWSWIRE
    28 May 2024
    Share Share
    Enveric Strengthens IP with New U.S. Patent for Tryptamine-derived Prodrugs
    Enveric Strengthens IP with New U.S. Patent for Tryptamine-derived Prodrugs

    28 Aug 2023

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20230825084724/en

    BUSINESSWIRE
    28 Aug 2023
    Share Share
    Enveric Bio Files Portfolio of Patent Applications for Tryptamine-Based Molecule
    Enveric Bio Files Portfolio of Patent Applications for Tryptamine-Based Molecule

    01 Mar 2022

    // PRNEWSWIRE

    https://www.prnewswire.com/news-releases/enveric-biosciences-files-portfolio-of-patent-applications-for-tryptamine-based-molecules-301492335.html

    PRNEWSWIRE
    01 Mar 2022
    Share Share
    Algernon Files for Trial and Ethics Approval for Phase 1 DMT Human Stroke Study
    Algernon Files for Trial and Ethics Approval for Phase 1 DMT Human Stroke Study

    19 Jan 2022

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2022/01/19/2369181/0/en/Algernon-Pharmaceuticals-Files-for-Clinical-Trial-and-Ethics-Approval-for-Phase-1-DMT-Human-Stroke-Study.html

    GLOBENEWSWIRE
    19 Jan 2022
    Share Share